{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:48:52Z","timestamp":1789778932634,"version":"4.0.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pudong New Area Science and Technology Development Fund","award":["PKJ2021-Y31"],"award-info":[{"award-number":["PKJ2021-Y31"]}]},{"name":"Clinical Research Fund of Shanghai Municipal Commission of Health","award":["202240112"],"award-info":[{"award-number":["202240112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11914-025-00914-5","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:47:56Z","timestamp":1744134476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Laboratory-based Biomarkers for Risk Prediction, Auxiliary Diagnosis and Post-operative Follow-up of Osteoporotic Fractures"],"prefix":"10.1007","volume":"23","author":[{"given":"Rui","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-pin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-6814","authenticated-orcid":false,"given":"Sheng-li","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"11","key":"914_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908\u201323.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"914_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/PHM.0b013e31821f6df3","volume":"90","author":"M Pfeifer","year":"2011","unstructured":"Pfeifer M, Kohlwey L, Begerow B, Minne HW. Effects of two newly developed spinal orthoses on trunk muscle strength, posture, and quality-of-life in women with postmenopausal osteoporosis: a randomized trial. Am J Phys Med Rehabil. 2011;90(10):805\u201315.","journal-title":"Am J Phys Med Rehabil"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"687551","DOI":"10.3389\/fimmu.2021.687551","volume":"12","author":"D Wu","year":"2021","unstructured":"Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol. 2021;12:687551.","journal-title":"Front Immunol."},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12891-016-0952-8","volume":"17","author":"JH Lee","year":"2016","unstructured":"Lee JH, Sung YK, Choi CB, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17:98.","journal-title":"BMC Musculoskelet Disord."},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"5567666","DOI":"10.1155\/2021\/5567666","volume":"2021","author":"CA Nava-Valdivia","year":"2021","unstructured":"Nava-Valdivia CA, Ponce-Guarneros JM, Saldana-Cruz AM, et al. Assessment of serum sRANKL, sRANKL\/OPG ratio, and other bone turnover markers with the estimated 10-year risk of major and hip osteoporotic fractures in rheumatoid arthritis: A cross-sectional study. Biomed Res Int. 2021;2021:5567666.","journal-title":"Biomed Res Int."},{"issue":"9","key":"914_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/1753-0407.13309","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Wang G, Wu T, Hu J, Mu Y, Gu W. Association of skin autofluorescence with low bone density\/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus. J Diabetes. 2022;14(9):571\u201385.","journal-title":"J Diabetes"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"910934","DOI":"10.3389\/fendo.2022.910934","volume":"13","author":"S Lincoln","year":"2022","unstructured":"Lincoln S, Morse LR, Troy K, Mattson N, Nguyen N, Battaglino RA. MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury. Front Endocrinol (Lausanne). 2022;13:910934.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"914_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3\u201344.","journal-title":"Osteoporos Int"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","volume":"6","author":"O Strom","year":"2011","unstructured":"Strom O, Borgstrom F, Kanis JA, et al. Osteoporosis: burden, health care provision and opportunities in the EU: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2011;6:59\u2013155.","journal-title":"Arch Osteoporos."},{"issue":"1","key":"914_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16(1):82.","journal-title":"Arch Osteoporos"},{"issue":"3","key":"914_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jbmr.4187","volume":"36","author":"X Cheng","year":"2021","unstructured":"Cheng X, Zhao K, Zha X, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: A nationwide. Multicenter Study J Bone Miner Res. 2021;36(3):427\u201335.","journal-title":"Multicenter Study J Bone Miner Res"},{"issue":"3","key":"914_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-022-00996-8","volume":"111","author":"KK Ivaska","year":"2022","unstructured":"Ivaska KK, McGuigan FE, Malmgren L, et al. Bone turnover marker profiling and fracture risk in older women: fracture risk from age 75 to 90. Calcif Tissue Int. 2022;111(3):288\u201399.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"914_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","volume":"16","author":"JT Schousboe","year":"2013","unstructured":"Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry. J Clin Densitom. 2013;16(4):455\u201366.","journal-title":"J Clin Densitom"},{"issue":"4","key":"914_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00198-004-1779-y","volume":"16","author":"KG Faulkner","year":"2005","unstructured":"Faulkner KG. The tale of the T-score: Review and perspective. Osteoporos Int. 2005;16(4):347\u201352.","journal-title":"Osteoporos Int"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2017.01.024","volume":"104","author":"EM Curtis","year":"2017","unstructured":"Curtis EM, Moon RJ, Harvey NC, Cooper C. The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone. 2017;104:29\u201338.","journal-title":"Bone."},{"issue":"24","key":"914_CR16","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2018.6537","volume":"319","author":"M Viswanathan","year":"2018","unstructured":"Viswanathan M, Reddy S, Berkman N, et al. Screening to prevent osteoporotic fractures: Updated evidence report and systematic review for the us preventive services task force. JAMA. 2018;319(24):2532\u201351.","journal-title":"JAMA"},{"issue":"3","key":"914_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11914-009-0013-4","volume":"7","author":"EV McCloskey","year":"2009","unstructured":"McCloskey EV, Johansson H, Oden A, Kanis JA. From relative risk to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep. 2009;7(3):77\u201383.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"914_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jocd.2017.06.013","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Oden A, McCloskey EV, Leslie WD. Overview of fracture prediction tools. J Clin Densitom. 2017;20(3):444\u201350.","journal-title":"J Clin Densitom"},{"issue":"2","key":"914_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464\u201374.","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"914_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1\u201346.","journal-title":"Endocr Pract"},{"key":"914_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cca.2019.08.012","volume":"498","author":"Y Nishizawa","year":"2019","unstructured":"Nishizawa Y, Miura M, Ichimura S, et al. Executive summary of the Japan osteoporosis society guide for the use of bone turnover markers in the diagnosis and treatment of osteoporosis (2018 Edition). Clin Chim Acta. 2019;498:101\u20137.","journal-title":"Clin Chim Acta."},{"issue":"1","key":"914_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12891-024-07560-5","volume":"25","author":"J Zhang","year":"2024","unstructured":"Zhang J, Hu Y, Cai W. Bone metabolism factors in predicting the risk of osteoporosis fracture in the elderly. BMC Musculoskelet Disord. 2024;25(1):442.","journal-title":"BMC Musculoskelet Disord"},{"issue":"19","key":"914_CR23","doi-asserted-by":"publisher","first-page":"17491","DOI":"10.1074\/jbc.M210529200","volume":"278","author":"M Mongiat","year":"2003","unstructured":"Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003;278(19):17491\u20139.","journal-title":"J Biol Chem"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"105166","DOI":"10.1016\/j.jprot.2024.105166","volume":"300","author":"Y Nakai","year":"2024","unstructured":"Nakai Y, Kumagai K, Ino Y, et al. Use of data-independent acquisition mass spectrometry to identify an objective serum indicator of the need for osteoporotic therapeutic intervention. J Proteomics. 2024;300:105166.","journal-title":"J Proteomics."},{"issue":"6","key":"914_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","volume":"82","author":"W Balemans","year":"2008","unstructured":"Balemans W, Piters E, Cleiren E, et al. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif Tissue Int. 2008;82(6):445\u201353.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"914_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","volume":"24","author":"P Garnero","year":"2013","unstructured":"Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2013;24(2):489\u201394.","journal-title":"Osteoporos Int"},{"issue":"6","key":"914_CR27","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2011-3419","volume":"97","author":"A Arasu","year":"2012","unstructured":"Arasu A, Cawthon PM, Lui LY, et al. Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab. 2012;97(6):2027\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"914_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","volume":"49","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Cooper C, Eastell R, et al. International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med. 2011;49(8):1271\u20134.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"914_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/os.12701","volume":"12","author":"J Zhou","year":"2020","unstructured":"Zhou J, Liu B, Qin MZ, Liu JP. Fall prevention and anti-osteoporosis in osteopenia patients of 80 years of age and older: A randomized controlled study. Orthop Surg. 2020;12(3):890\u20139.","journal-title":"Orthop Surg"},{"key":"914_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2017.12.015","volume":"477","author":"J Fan","year":"2018","unstructured":"Fan J, Li N, Gong X, He L. Serum 25-hydroxyvitamin D, bone turnover markers and bone mineral density in postmenopausal women with hip fractures. Clin Chim Acta. 2018;477:135\u201340.","journal-title":"Clin Chim Acta."},{"issue":"11","key":"914_CR31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/GME.0000000000002257","volume":"30","author":"X Zhu","year":"2023","unstructured":"Zhu X, Chen L, Pan L, et al. Correlation between bone mineral density and bone metabolic markers in postmenopausal women with osteoporotic fractures at different C-terminal telopeptide of type 1 collagen levels: A retrospective analysis study. Menopause. 2023;30(11):1139\u201346.","journal-title":"Menopause"},{"issue":"2","key":"914_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008;29(2):155\u201392.","journal-title":"Endocr Rev"},{"issue":"2","key":"914_CR33","first-page":"5","volume":"5","author":"JE Aubin","year":"2000","unstructured":"Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health. 2000;5(2):5.","journal-title":"Medscape Womens Health"},{"key":"914_CR34","doi-asserted-by":"publisher","first-page":"115404","DOI":"10.1016\/j.bone.2020.115404","volume":"137","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Nakano M, Suzuki T, et al. Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women. Bone. 2020;137:115404.","journal-title":"Bone."},{"issue":"1","key":"914_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00774-021-01266-7","volume":"40","author":"C Kuriakose","year":"2022","unstructured":"Kuriakose C, Cherian KE, Jebasingh F, et al. The prevalence of vertebral fractures among Indian perimenopausal women and its association with ovarian biomarkers. J Bone Miner Metab. 2022;40(1):142\u20139.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"914_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jcsm.13447","volume":"15","author":"D Di","year":"2024","unstructured":"Di D, Zhou H, Cui Z, et al. Frailty phenotype as mediator between systemic inflammation and osteoporosis and fracture risks: A prospective study. J Cachexia Sarcopenia Muscle. 2024;15(3):897\u2013906.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"914_CR37","doi-asserted-by":"publisher","first-page":"e23016","DOI":"10.1002\/jcla.23016","volume":"34","author":"H Fang","year":"2020","unstructured":"Fang H, Zhang H, Wang Z, Zhou Z, Li Y, Lu L. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal. 2020;34(1):e23016.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"914_CR38","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/jbmr.2245","volume":"29","author":"KE Barbour","year":"2014","unstructured":"Barbour KE, Lui LY, Ensrud KE, et al. Inflammatory markers and risk of hip fracture in older white women: the study of osteoporotic fractures. J Bone Miner Res. 2014;29(9):2057\u201364.","journal-title":"J Bone Miner Res"},{"key":"914_CR39","doi-asserted-by":"publisher","first-page":"8691830","DOI":"10.1155\/2022\/8691830","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Y, Qi B, et al. IL-6 and Leptin are potential biomarkers for osteoporotic fracture risk assessment and prediction of postmenopausal women with low bone mass: A follow-up study using a regional sample cohort. Oxid Med Cell Longev. 2022;2022:8691830.","journal-title":"Oxid Med Cell Longev."},{"issue":"3","key":"914_CR40","doi-asserted-by":"publisher","first-page":"e1004191","DOI":"10.1371\/journal.pgen.1004191","volume":"10","author":"M Weischer","year":"2014","unstructured":"Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014;10(3):e1004191.","journal-title":"PLoS Genet"},{"issue":"6","key":"914_CR41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s00774-019-01004-0","volume":"37","author":"L Tao","year":"2019","unstructured":"Tao L, Huang Q, Yang R, et al. The age modification to leukocyte telomere length effect on bone mineral density and osteoporosis among Chinese elderly women. J Bone Miner Metab. 2019;37(6):1004\u201312.","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"914_CR42","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jbmr.4664","volume":"37","author":"EM Curtis","year":"2022","unstructured":"Curtis EM, Codd V, Nelson C, et al. Telomere length and risk of incident fracture and arthroplasty: Findings from UK biobank. J Bone Miner Res. 2022;37(10):1997\u20132004.","journal-title":"J Bone Miner Res"},{"key":"914_CR43","doi-asserted-by":"publisher","first-page":"1179521","DOI":"10.3389\/fendo.2023.1179521","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Feng L, Lix LM, et al. Global biomarkers of oxidative stress and fractures: a matched case-control study. Front Endocrinol (Lausanne). 2023;14:1179521.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"914_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","volume":"314","author":"XC Bai","year":"2004","unstructured":"Bai XC, Lu D, Bai J, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 2004;314(1):197\u2013207.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"914_CR45","doi-asserted-by":"publisher","first-page":"e0277452","DOI":"10.1371\/journal.pone.0277452","volume":"18","author":"D Kim","year":"2023","unstructured":"Kim D, Kim JH, Lee H, Hong I, Chang Y, Song TJ. Association of gamma-glutamyl transferase variability with risk of osteoporotic fractures: A nationwide cohort study. PLoS ONE. 2023;18(6):e0277452.","journal-title":"PLoS ONE"},{"issue":"6","key":"914_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00198-022-06307-z","volume":"33","author":"W Brozek","year":"2022","unstructured":"Brozek W, Ulmer H, Pompella A, et al. Gamma-glutamyl-transferase is associated with incident hip fractures in women and men >\/= 50 years: a large population-based cohort study. Osteoporos Int. 2022;33(6):1295\u2013307.","journal-title":"Osteoporos Int"},{"issue":"1","key":"914_CR47","doi-asserted-by":"publisher","first-page":"13947","DOI":"10.1038\/s41598-022-18453-9","volume":"12","author":"KJ Kim","year":"2022","unstructured":"Kim KJ, Hong N, Yu MH, et al. Elevated gamma-glutamyl transpeptidase level is associated with an increased risk of hip fracture in postmenopausal women. Sci Rep. 2022;12(1):13947.","journal-title":"Sci Rep"},{"issue":"5543","key":"914_CR48","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1065329","volume":"294","author":"RC Lee","year":"2001","unstructured":"Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001;294(5543):862\u20134.","journal-title":"Science"},{"issue":"4","key":"914_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","volume":"8","author":"JB Lian","year":"2012","unstructured":"Lian JB, Stein GS, van Wijnen AJ, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 2012;8(4):212\u201327.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"914_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ijos.2015.22","volume":"7","author":"D Jing","year":"2015","unstructured":"Jing D, Hao J, Shen Y, et al. The role of microRNAs in bone remodeling. Int J Oral Sci. 2015;7(3):131\u201343.","journal-title":"Int J Oral Sci"},{"issue":"13","key":"914_CR51","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.7150\/thno.55664","volume":"11","author":"MR Iaquinta","year":"2021","unstructured":"Iaquinta MR, Lanzillotti C, Mazziotta C, et al. The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. Theranostics. 2021;11(13):6573\u201391.","journal-title":"Theranostics"},{"issue":"22","key":"914_CR52","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2217\/epi-2020-0233","volume":"12","author":"S Fittipaldi","year":"2020","unstructured":"Fittipaldi S, Visconti VV, Tarantino U, Novelli G, Botta A. Genetic variability in noncoding RNAs: involvement of miRNAs and long noncoding RNAs in osteoporosis pathogenesis. Epigenomics. 2020;12(22):2035\u201349.","journal-title":"Epigenomics"},{"issue":"8","key":"914_CR53","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/jbmr.2175","volume":"29","author":"C Seeliger","year":"2014","unstructured":"Seeliger C, Karpinski K, Haug AT, et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 2014;29(8):1718\u201328.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"914_CR54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00223-015-0036-z","volume":"97","author":"L Panach","year":"2015","unstructured":"Panach L, Mifsut D, Tarin JJ, Cano A, Garcia-Perez MA. Serum circulating microRNAs as biomarkers of osteoporotic fracture. Calcif Tissue Int. 2015;97(5):495\u2013505.","journal-title":"Calcif Tissue Int"},{"key":"914_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bone.2018.11.001","volume":"120","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bemben MG, Bemben DA. Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status. Bone. 2019;120:271\u20138.","journal-title":"Bone."},{"issue":"3","key":"914_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00223-019-00628-8","volume":"106","author":"A Ladang","year":"2020","unstructured":"Ladang A, Beaudart C, Locquet M, Reginster JY, Bruyere O, Cavalier E. Evaluation of a panel of MicroRNAs that predicts fragility fracture risk: A pilot study. Calcif Tissue Int. 2020;106(3):239\u201347.","journal-title":"Calcif Tissue Int"},{"key":"914_CR57","doi-asserted-by":"publisher","first-page":"3838126","DOI":"10.1155\/2022\/3838126","volume":"2022","author":"J Xu","year":"2022","unstructured":"Xu J, Li M, Pei W, et al. Reduced circulating levels of miR-491\u20135p and miR-485\u20133p are associated with the occurrence of vertebral fractures in postmenopausal women with osteoporosis. Genet Res (Camb). 2022;2022:3838126.","journal-title":"Genet Res (Camb)."},{"key":"914_CR58","doi-asserted-by":"publisher","first-page":"116308","DOI":"10.1016\/j.bone.2021.116308","volume":"158","author":"U Heilmeier","year":"2022","unstructured":"Heilmeier U, Hackl M, Schroeder F, et al. Circulating serum microRNAs including senescent miR-31\u20135p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus. Bone. 2022;158:116308.","journal-title":"Bone."},{"key":"914_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13098-020-00561-z","volume":"12","author":"T Takata","year":"2020","unstructured":"Takata T, Sakasai-Sakai A, Takeuchi M. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death. Diabetol Metab Syndr. 2020;12:54.","journal-title":"Diabetol Metab Syndr."},{"issue":"2","key":"914_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21(2):195\u2013214.","journal-title":"Osteoporos Int"},{"issue":"6","key":"914_CR61","doi-asserted-by":"publisher","first-page":"992","DOI":"10.31616\/asj.2018.12.6.992","volume":"12","author":"DH Choi","year":"2018","unstructured":"Choi DH, Lee SM, Lim SA, Choi YS. Feasibility of serum pentosidine level as a potential risk factor for osteoporotic vertebral compression fracture. Asian Spine J. 2018;12(6):992\u20137.","journal-title":"Asian Spine J"},{"issue":"10","key":"914_CR62","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/jbmr.4096","volume":"35","author":"K Waqas","year":"2020","unstructured":"Waqas K, Chen J, Koromani F, et al. Skin autofluorescence, a noninvasive biomarker for advanced glycation end-products, is associated with prevalent vertebral and major osteoporotic fractures: The Rotterdam study. J Bone Miner Res. 2020;35(10):1904\u201313.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"914_CR63","first-page":"e5021","volume":"106","author":"AL Eriksson","year":"2021","unstructured":"Eriksson AL, Friedrich N, Karlsson MK, et al. Serum glycine levels are associated with cortical bone properties and fracture risk in men. J Clin Endocrinol Metab. 2021;106(12):e5021\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"914_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/diagnostics10030145","volume":"10","author":"FF Ramli","year":"2020","unstructured":"Ramli FF, Chin KY. A review of the potential application of osteocyte-related biomarkers, fibroblast growth factor-23, Sclerostin, and dickkopf-1 in predicting osteoporosis and fractures. Diagnostics (Basel). 2020;10(3):145.","journal-title":"Diagnostics (Basel)."},{"issue":"6","key":"914_CR65","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1007\/s00068-022-02017-7","volume":"48","author":"EA Gorter","year":"2022","unstructured":"Gorter EA, Reinders CR, Krijnen P, Appelman-Dijkstra NM, Schipper IB. Serum sclerostin levels in osteoporotic fracture patients. Eur J Trauma Emerg Surg. 2022;48(6):4857\u201365.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"8","key":"914_CR66","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00198-021-05847-0","volume":"32","author":"K Eastman","year":"2021","unstructured":"Eastman K, Gerlach M, Piec I, Greeves J, Fraser W. Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis. Osteoporos Int. 2021;32(8):1531\u201346.","journal-title":"Osteoporos Int"},{"issue":"2","key":"914_CR67","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jor.23767","volume":"36","author":"F Tian","year":"2018","unstructured":"Tian F, Wang Y, Bikle DD. IGF-1 signaling mediated cell-specific skeletal mechano-transduction. J Orthop Res. 2018;36(2):576\u201383.","journal-title":"J Orthop Res"},{"key":"914_CR68","doi-asserted-by":"publisher","first-page":"902186","DOI":"10.1155\/2014\/902186","volume":"2014","author":"G Colaianni","year":"2014","unstructured":"Colaianni G, Cuscito C, Mongelli T, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol. 2014;2014:902186.","journal-title":"Int J Endocrinol."},{"issue":"5","key":"914_CR69","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00198-014-2673-x","volume":"25","author":"AD Anastasilakis","year":"2014","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, et al. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Osteoporos Int. 2014;25(5):1633\u201342.","journal-title":"Osteoporos Int"},{"issue":"4","key":"914_CR70","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cen.12672","volume":"82","author":"A Palermo","year":"2015","unstructured":"Palermo A, Strollo R, Maddaloni E, et al. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf). 2015;82(4):615\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"914_CR71","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jbspin.2017.03.011","volume":"85","author":"J Yan","year":"2018","unstructured":"Yan J, Liu HJ, Guo WC, Yang J. Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women. Joint Bone Spine. 2018;85(3):353\u20138.","journal-title":"Joint Bone Spine"},{"key":"914_CR72","doi-asserted-by":"publisher","first-page":"155708","DOI":"10.1016\/j.cyto.2021.155708","volume":"148","author":"K Liu","year":"2021","unstructured":"Liu K, Jing P, Liu Z, et al. Serum levels of irisin in postmenopausal women with osteoporotic hip fractures. Cytokine. 2021;148:155708.","journal-title":"Cytokine."},{"issue":"6","key":"914_CR73","doi-asserted-by":"publisher","first-page":"e28799","DOI":"10.1097\/MD.0000000000028799","volume":"101","author":"JI Gamez-Nava","year":"2022","unstructured":"Gamez-Nava JI, Ramirez-Villafana M, Cons-Molina F, et al. Serum irisin concentrations and osteoporotic vertebral fractures in women with rheumatoid arthritis: A cross-sectional study. Medicine (Baltimore). 2022;101(6):e28799.","journal-title":"Medicine (Baltimore)"},{"key":"914_CR74","doi-asserted-by":"publisher","first-page":"108187","DOI":"10.1016\/j.abb.2019.108187","volume":"679","author":"J Wang","year":"2020","unstructured":"Wang J, Gao Y, Lin F, Han K, Wang X. Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4\/MyD88\/NF-kappaB signaling. Arch Biochem Biophys. 2020;679:108187.","journal-title":"Arch Biochem Biophys."},{"issue":"2","key":"914_CR75","first-page":"308","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, Hou Y, Wang Z, et al. Study on Omentin-1 and miR-502-3p in osteoporotic fracture. J Musculoskelet Neuronal Interact. 2021;21(2):308\u201316.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"2","key":"914_CR76","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/cells9020479","volume":"9","author":"A Smieszek","year":"2020","unstructured":"Smieszek A, Marcinkowska K, Pielok A, Sikora M, Valihrach L, Marycz K. The role of miR-21 in osteoblasts-osteoclasts coupling in vitro. Cells. 2020;9(2):479.","journal-title":"Cells."},{"issue":"3","key":"914_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/jom-2023-0174","volume":"124","author":"ZX Si","year":"2024","unstructured":"Si ZX, Zhou SF, Shen ZL, Yan JL. Increased circulating microRNA-21 level as a potential indicator for predicting a higher risk of incident fragility fractures. J Osteopath Med. 2024;124(3):121\u20135.","journal-title":"J Osteopath Med"},{"issue":"8","key":"914_CR78","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1210\/clinem\/dgac293","volume":"107","author":"S Ciuffi","year":"2022","unstructured":"Ciuffi S, Marini F, Fossi C, et al. Circulating MicroRNAs as biomarkers of osteoporosis and fragility fractures. J Clin Endocrinol Metab. 2022;107(8):2267\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"914_CR79","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1210\/jc.2016-2365","volume":"101","author":"R Kocijan","year":"2016","unstructured":"Kocijan R, Muschitz C, Geiger E, et al. Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures. J Clin Endocrinol Metab. 2016;101(11):4125\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"914_CR80","first-page":"204","volume":"29","author":"Y Lei","year":"2023","unstructured":"Lei Y, Yu L, Tang G, Liu A. Circulating miR-4739 and IGFBP-4 levels in postmenopausal women with osteoporosis and osteoporotic vertebral fracture. Altern Ther Health Med. 2023;29(7):204\u20139.","journal-title":"Altern Ther Health Med"},{"key":"914_CR81","doi-asserted-by":"crossref","unstructured":"Pertusa C, Tarin JJ, Cano A, Garcia-Perez MA, Mifsut D. Serum microRNAs in osteoporotic fracture and osteoarthritis: a genetic and functional study. Sci Rep. 2021;11(1):19372.","DOI":"10.1038\/s41598-021-98789-w"},{"issue":"2","key":"914_CR82","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jbmr.3892","volume":"35","author":"M Sun","year":"2020","unstructured":"Sun M, Hu L, Wang S, et al. Circulating microRNA-19b identified from osteoporotic vertebral compression fracture patients increases bone formation. J Bone Miner Res. 2020;35(2):306\u201316.","journal-title":"J Bone Miner Res"},{"key":"914_CR83","doi-asserted-by":"publisher","first-page":"121693","DOI":"10.1016\/j.lfs.2023.121693","volume":"323","author":"ZZ Zheng","year":"2023","unstructured":"Zheng ZZ, Xu JH, Dai Y, et al. Circulating miR-107 as a diagnostic biomarker of osteoporotic vertebral compression fracture increases bone formation in vitro and in vivo. Life Sci. 2023;323:121693.","journal-title":"Life Sci."},{"issue":"5","key":"914_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14744\/tjtes.2024.48409","volume":"30","author":"KE Altinsoy","year":"2024","unstructured":"Altinsoy KE, Unat B. The role of bone turnover markers in diagnosis, monitoring, and pathological fractures of osteoporosis. Ulus Travma Acil Cerrahi Derg. 2024;30(5):323\u20137.","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"22","key":"914_CR85","first-page":"10860","volume":"27","author":"XB Lin","year":"2023","unstructured":"Lin XB, Ye H, He LJ, Xu ZB. Analysis of changes in serum high t-PINP\/beta-CTX ratio and risk of re-fracture after vertebral osteoporotic fracture surgery. Eur Rev Med Pharmacol Sci. 2023;27(22):10860\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"914_CR86","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00774-021-01242-1","volume":"39","author":"Y Sakai","year":"2021","unstructured":"Sakai Y, Wakao N, Matsui H, Watanabe T, Iida H, Katsumi A. Elevated red blood cell distribution width is associated with poor outcome in osteoporotic vertebral fracture. J Bone Miner Metab. 2021;39(6):1048\u201357.","journal-title":"J Bone Miner Metab"},{"key":"914_CR87","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fendo.2018.00587","volume":"9","author":"QY Wu","year":"2018","unstructured":"Wu QY, Li X, Miao ZN, et al. Long non-coding RNAs: A new regulatory code for osteoporosis. Front Endocrinol (Lausanne). 2018;9:587.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"7","key":"914_CR88","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.18632\/aging.204001","volume":"14","author":"R Li","year":"2022","unstructured":"Li R, Shi TT, Wang Q, Zhang YX. Elevated lncRNA MIAT in peripheral blood mononuclear cells contributes to post-menopausal osteoporosis. Aging (Albany NY). 2022;14(7):3143\u201354.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"914_CR89","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13018-024-04824-7","volume":"19","author":"C Yu","year":"2024","unstructured":"Yu C, Chen B, Su H, Yang Y. Long non-coding RNA MIAT serves as a biomarker of fragility fracture and promotes fracture healing. J Orthop Surg Res. 2024;19(1):343.","journal-title":"J Orthop Surg Res"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-025-00914-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:14:23Z","timestamp":1768472063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-025-00914-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s11914-025-00914-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"26 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"19"}}